Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

NCT00278200 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Lymphoproliferative Disorder

Interventions

BIOLOGICAL: Inactivated EBV-infected vaccine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]